Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

Irvine, California

Cancer surgery and procedure trials in Irvine, CA

45 cancer surgery and procedure studies are recruiting participants at sites in Irvine as of November 18, 2026, according to ClinicalTrials.gov. Cancer Surgery Trials can help you understand your options and connect with a study team.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Irvine at a glance

  • 45 studies are recruiting at a site in Irvine.
  • By phase: Phase 1 (6), Phase 1/2 (2), Phase 2 (16), Phase 2/3 (1), Phase 3 (18), No phase (2). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (27), government (17), industry (1).
  • By research area: Lymphoma (20), Breast Cancer (7), Lung Cancer (7), Prostate Cancer (5), Melanoma (3), Pancreatic Cancer (3).
  • Most recent update to one of these records: November 18, 2026.

Breast cancer studies recruiting in Irvine

Basic details from each study's public record (the 30 most recently updated of 45). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT07391774 · updated
  2. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    City of Hope at Irvine Lennar · UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT06058377 · updated
  3. Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT06260033 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Irvine, CA on ClinicalTrials.gov.

Lung cancer studies recruiting in Irvine

  1. Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Kaiser Permanente-Irvine
    Registry record
    NCT07388524 · updated
  2. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT06287775 · updated
  3. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Kaiser Permanente-Irvine
    Registry record
    NCT04267848 · updated
  4. Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT05830058 · updated
  5. Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT07288034 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Irvine, CA on ClinicalTrials.gov.

Prostate cancer studies recruiting in Irvine

  1. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    City of Hope at Irvine Lennar · UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT07200830 · updated
  2. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    NRG Oncology
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT05946213 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Irvine, CA on ClinicalTrials.gov.

Melanoma studies recruiting in Irvine

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT05136196 · updated
  2. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Irvine, CA on ClinicalTrials.gov.

Lymphoma studies recruiting in Irvine

  1. Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT03739814 · updated
  2. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    City of Hope at Irvine Lennar · UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT06337318 · updated
  3. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT06724237 · updated
  4. Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    City of Hope at Irvine Lennar · Kaiser Permanente-Irvine · UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT04269902 · updated
  5. Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT04840602 · updated
  6. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    • Phase 3
    • Ages 5 to 60
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    City of Hope at Irvine Lennar · UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT05675410 · updated
  7. Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT07582159 · updated
  8. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

    • Phase 3
    • Ages 18 to 39
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT03150693 · updated
  9. Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT07215910 · updated
  10. Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

    • Phase 3
    • Ages 65 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Kaiser Permanente-Irvine
    Registry record
    NCT07321652 · updated
  11. Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

    • Phase 2
    • Ages 60 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT06052826 · updated
  12. Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT06860594 · updated
  13. Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT07332507 · updated
  14. Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT05633615 · updated
  15. Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT07069699 · updated
  16. Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

    • Phase 2
    • Ages 18 to 54
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope at Irvine Lennar
    Registry record
    NCT06918431 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Irvine, CA on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Irvine

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    City of Hope at Irvine Lennar · UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT05372614 · updated
  2. Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
    Registry record
    NCT05687123 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Irvine, CA on ClinicalTrials.gov.

Ask about studies near Irvine

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call